AKR4C8 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (made-to-order)
Synonyms
AKR4C8 antibody; At2g37760 antibody; F13M22 antibody; T8P21.6Aldo-keto reductase family 4 member C8 antibody; EC 1.1.1.- antibody
Target Names
AKR4C8
Uniprot No.

Target Background

Function
AKR4C8 is an oxidoreductase with broad substrate specificity. It catalyzes the reduction of ketosteroids, aromatic aldehydes, ketones, sugars, and other aliphatic aldehydes, as well as the oxidation of hydroxysteroids. This enzyme may function as a detoxification agent by reducing various toxic aldehydes and ketones generated under stress conditions.
Database Links

KEGG: ath:AT2G37760

STRING: 3702.AT2G37760.1

UniGene: At.12802

Protein Families
Aldo/keto reductase family

Q&A

Basic Research Questions

  • What is AKR4C8 and why are antibodies against it important for research?

    AKR4C8 (AT2G37760) is a NAD(P)-linked oxidoreductase superfamily protein in Arabidopsis thaliana, specifically an aldo-keto reductase family 4 member . This enzyme belongs to the broader AKR family characterized by an (α/β)8-barrel structural motif, a conserved cofactor binding domain, and a catalytic tetrad . AKR enzymes typically reduce reactive ketones and aldehydes to corresponding alcohols or perform reverse oxidation reactions, with AKR4C8 being NADPH-dependent (unlike GSNOR which uses NADH) .

    Antibodies against AKR4C8 are crucial research tools because:

    • They enable detection and quantification of AKR4C8 in plant tissues

    • They facilitate investigation of the protein's role in stress responses

    • They help elucidate AKR4C8's potential involvement in NO/GSNO homeostasis

    • They allow comparative studies of expression patterns across tissue types and under different conditions

  • What applications are most suitable for AKR4C8 antibodies in plant molecular biology?

    AKR4C8 antibodies have demonstrated utility in multiple applications:

    • Western blotting (WB): Typically used at dilutions of 1:5000 for detecting AKR4C8 in plant protein extracts

    • Immunohistochemistry (IHC): Enables visualization of protein localization in plant tissues

    • Immunoprecipitation (IP): Can isolate AKR4C8 and associated protein complexes

    • ELISA: Allows quantitative measurement of AKR4C8 levels

    When designing experiments, researchers should consider:

    • Sample preparation methods (fresh vs. fixed tissues)

    • Extraction buffers (typically 50 mM Tris-HCl, pH 7.9, 0.2% Triton X-100, with protease inhibitors)

    • Blocking conditions (10% w/v fat-free milk in TBST is commonly used)

    • Secondary antibody selection (anti-rabbit IgG HRP-conjugated antibodies at 1:10,000 dilution work well)

  • How should AKR4C8 antibodies be stored and handled for optimal performance?

    Based on general antibody handling principles and specific information from plant antibody protocols:

    • Storage: Store at -20°C in small aliquots to prevent repeated freeze-thaw cycles

    • Working solutions: Keep on ice while in use

    • Formulation: Most research-grade antibodies come in Tris Buffered Saline, pH 7.3, with 0.5% BSA and 0.02% Sodium Azide

    • Expiration: Validate antibody performance periodically, especially after prolonged storage

    • Reconstitution: If lyophilized, reconstitute using sterile techniques with recommended buffer

    A stability testing workflow is recommended for laboratories routinely using these antibodies:

    1. Aliquot new antibody batch into single-use volumes

    2. Test performance on known positive controls

    3. Document signal-to-noise ratio

    4. Retest periodically to monitor potential degradation

  • What controls should be included when using AKR4C8 antibodies?

    Rigorous experimental design requires appropriate controls:

    • Positive control: Extract from wild-type Arabidopsis thaliana tissues known to express AKR4C8

    • Negative control: Extract from knockout or knockdown plants (e.g., T-DNA insertion lines)

    • Specificity control: Pre-absorption with immunizing peptide or purified AKR4C8 protein

    • Loading control: Anti-actin antibodies (e.g., Agrisera AS13 2640, 1:3000 dilution)

    • Isotype control: Irrelevant antibody of same isotype and host species (e.g., Goat IgG for polyclonal goat antibodies)

    Inclusion of these controls helps validate results and troubleshoot potential issues with antibody specificity or sample preparation.

Advanced Research Questions

  • How can cross-reactivity between AKR4C8 antibodies and other AKR family proteins be assessed and mitigated?

    Cross-reactivity is a significant concern when working with AKR4C8 antibodies due to high sequence homology among AKR family members. Assessment and mitigation strategies include:

    Assessment methods:

    • Comparative Western blotting: Test antibody against recombinant AKR4C8, AKR4C9, AKR4C10, and AKR4C11 proteins

    • Peptide competition assays: Pre-incubate antibody with immunizing peptide or with peptides from homologous regions of related proteins

    • Knockout validation: Test in tissues from AKR4C8 knockout plants while maintaining expression of other AKR family members

    • Epitope mapping: Identify the specific epitope recognized by the antibody and compare with sequence alignments

    Mitigation strategies:

    • Custom antibody design: Generate antibodies against unique regions of AKR4C8 that differ from other AKR family members

    • Affinity purification: Purify antibodies using immobilized AKR4C8-specific peptides

    • Computational antibody engineering: Apply newer approaches like those described in the DyAb platform to optimize antibody specificity

    • Sequential immunoprecipitation: Deplete cross-reactive antibodies before using for specific detection

    When using commercial antibodies, carefully review cross-reactivity data in product documentation, as some AKR4C8 antibodies may cross-react with other family members like AKR4C9 .

  • What are the optimal parameters for quantitative Western blot analysis of AKR4C8 in plant tissues?

    For quantitative Western blot analysis of AKR4C8:

    Sample preparation:

    • Homogenize 200 mg of plant material in 800 μl extraction buffer [50 mM Tris-HCl (pH 7.9), 0.2% (v/v) Triton X-100, protease inhibitor cocktail, 0.5 mM DTT]

    • Clarify by centrifugation (14,000×g, 15 minutes, 4°C)

    • Determine protein concentration using Bradford or BCA assay

    Electrophoresis and transfer parameters:

    • Use 12% acrylamide gels for optimal resolution of AKR4C8 (MW ~35-37 kDa)

    • Load equal amounts of protein (15-30 μg per lane)

    • Transfer to nitrocellulose membranes (45 μm) using semi-dry or wet transfer systems

    Detection optimization:

    • Primary antibody: Anti-AKR4C8 at 1:5000 dilution, overnight at 4°C

    • Secondary antibody: HRP-conjugated anti-rabbit IgG at 1:10,000, 60 min at room temperature

    • Signal development: Enhanced chemiluminescence (ECL) with optimized exposure times

    Quantification methodology:

    • Use digital imaging systems with linear dynamic range

    • Include calibration standards of purified AKR4C8 protein (if available)

    • Apply the Richards function for curve fitting in antibody reactivity quantification :

      R(x) = A · [1 + d · e^(-k·(x-xi))]^(-1/d)

    where A is antibody capacity, k is rate of exponential growth, d determines asymmetry, and xi is the point of fastest growth .

  • How can AKR4C8 antibodies be used to investigate its potential role in NO/GSNO homeostasis?

    Recent research has identified potential roles for AKR enzymes in NO/GSNO metabolism alongside GSNOR . To investigate AKR4C8's involvement:

    Experimental approaches:

    1. Co-localization studies:

      • Use anti-AKR4C8 antibodies alongside GSNOR antibodies in immunofluorescence experiments

      • Apply confocal microscopy to determine subcellular localization patterns

    2. Protein-protein interaction studies:

      • Immunoprecipitate AKR4C8 using specific antibodies and identify interacting partners by mass spectrometry

      • Perform co-immunoprecipitation experiments to test direct interaction with GSNOR or other NO metabolism proteins

    3. Activity correlation studies:

      • Compare AKR4C8 protein levels (detected by antibodies) with NADPH-dependent GSNO reductase activity

      • Perform enzyme assays using:

        • 100 mM Tris-HCl (pH 7.9)

        • 0.2 mM NADPH (not NADH, which is used by GSNOR)

        • 0.4 mM GSNO

        • Variable amounts of plant extracts (50-200 μg)

    4. Genetic approaches combined with immunodetection:

      • Analyze AKR4C8, AKR4C9, AKR4C10, and AKR4C11 protein levels in GSNOR mutant plants (e.g., atgsnor1-3 or hot5-2)

      • Compare expression patterns in response to NO donors, stress conditions, or pathogen challenge

  • What advanced techniques can improve the specificity and sensitivity of AKR4C8 antibody-based detection?

    Researchers can apply several cutting-edge approaches to enhance AKR4C8 detection:

    Antibody engineering strategies:

    • Computational antibody design: Apply machine learning models such as DyAb that integrate sequence-based and structure-based approaches to optimize antibody binding properties

    • Biophysics-informed modeling: Utilize models that account for both specific and cross-specific binding properties to redesign antibody binding regions

    Emerging detection platforms:

    • Single-molecule detection methods: Apply techniques like proximity ligation assay (PLA) for enhanced sensitivity

    • Microfluidic immunoassays: Develop miniaturized platforms requiring smaller sample volumes

    • Lateral flow immunoassays (LFIAs): Consider rapid detection formats with carefully calibrated specificity/sensitivity trade-offs

    Signal amplification methods:

    • Tyramide signal amplification: Can increase detection sensitivity by 10-100 fold

    • Quantum dot conjugation: Provides photostable fluorescent signal with minimal photobleaching

    • Polymer-HRP systems: Deliver enhanced chemiluminescent signal compared to conventional secondary antibodies

    Validation approaches:

    • Orthogonal detection: Confirm antibody results using mass spectrometry-based proteomics

    • CRISPR-based knockouts: Generate precise gene deletions as negative controls

    • Absolute quantification: Implement methods for determining absolute protein concentrations rather than relative levels

  • What considerations are important when developing custom AKR4C8 antibodies for specific research applications?

    When developing custom AKR4C8 antibodies, researchers should consider:

    Antigen design:

    • Unique epitope selection: Analyze sequence alignments of AKR family members to identify AKR4C8-specific regions

    • Structural considerations: Use protein structure prediction to identify surface-exposed regions

    • Functional domains: Avoid antibodies targeting active sites if enzymatic activity studies are planned

    • Post-translational modifications: Consider whether modifications might affect antibody recognition

    Production strategy:

    • Polyclonal vs. monoclonal: Polyclonals offer broader epitope recognition but potential batch variability; monoclonals provide consistency but narrower epitope recognition

    • Host species selection: Consider downstream applications (e.g., avoid rabbit hosts if studying rabbit tissues)

    • Recombinant antibody formats: Consider single-chain variable fragments (scFvs) or antigen-binding fragments (Fabs) for specialized applications

    Validation protocols:

    • Implement a multi-step validation workflow:

      1. ELISA against immunizing peptide/protein

      2. Western blot against recombinant protein and plant extracts

      3. Immunoprecipitation followed by mass spectrometry

      4. Testing in knockout/knockdown tissues

      5. Cross-reactivity assessment against related AKR proteins

    Experimental design considerations:

    • Expression system: For generating recombinant AKR4C8 as immunogen or standard, consider using the pET23b-HIS6-SUMO vector system with subsequent HIS6-SUMO tag removal via Ulp1 protease

    • Protein purification: Employ immobilized metal affinity chromatography (IMAC) followed by size exclusion chromatography

    • Quality control: Verify protein identity via mass spectrometry and measure purity by SDS-PAGE

  • How can researchers optimize immunohistochemical detection of AKR4C8 in plant tissues?

    Immunohistochemical detection of AKR4C8 in plant tissues requires special considerations:

    Tissue preparation protocols:

    • Fixation: Use 4% paraformaldehyde in phosphate buffer; avoid overfixation which can mask epitopes

    • Embedding: Paraffin embedding works well for general morphology; cryosectioning may better preserve antigenicity

    • Section thickness: 5-10 μm sections typically provide good resolution

    • Antigen retrieval: May be necessary after fixation; try citrate buffer (pH 6.0) heating method

    Blocking and antibody incubation:

    • Blocking solution: 5% BSA or 10% normal serum from secondary antibody host species

    • Primary antibody: Anti-AKR4C8 antibody at 2-4 μg/ml concentration

    • Incubation conditions: Overnight at 4°C in humid chamber

    • Washing: Multiple PBS-T washes to reduce background

    Detection systems:

    • Enzymatic: HRP or AP-conjugated secondary antibodies with appropriate substrates

    • Fluorescent: Fluorophore-conjugated secondary antibodies for confocal microscopy

    • Amplification: Consider tyramide signal amplification for low-abundance targets

    Controls and troubleshooting:

    • Positive control: Include tissue known to express AKR4C8

    • Negative controls: Omit primary antibody; use pre-immune serum

    • Autofluorescence mitigation: If using fluorescent detection, include protocols to reduce plant tissue autofluorescence (e.g., Sudan Black B treatment)

    • Signal-to-noise optimization: Titrate antibody concentrations; adjust incubation times and temperatures

  • What are the latest methodological advances in quantitative proteomics that could complement AKR4C8 antibody studies?

    Contemporary proteomics approaches that complement antibody-based AKR4C8 studies include:

    Mass spectrometry-based quantification:

    • Selected Reaction Monitoring (SRM): Targeted quantification of AKR4C8 peptides using heavy-labeled standards

    • Parallel Reaction Monitoring (PRM): Higher specificity than SRM for complex plant proteomes

    • Data-Independent Acquisition (DIA): Comprehensive analysis of the proteome including AKR4C8

    Sample preparation strategies:

    • Plant-specific extraction protocols: Optimize for reduction of interfering compounds (phenolics, polysaccharides)

    • Enrichment methods: Use antibody-based pulldown followed by MS analysis

    • Subcellular fractionation: Focus analysis on relevant cellular compartments

    Data analysis frameworks:

    • Quantitative proteome profiling: Apply similar approaches to those used in GSNOR mutant studies

    • Post-translational modification mapping: Identify regulatory modifications on AKR4C8

    • Protein-protein interaction networks: Place AKR4C8 in functional context

    Integration with other omics data:

    • Multi-omics approaches: Correlate protein levels with transcriptomics, metabolomics, and phenotypic data

    • Systems biology modeling: Incorporate AKR4C8 into pathway models of plant stress responses

    • Machine learning integration: Develop predictive models of AKR4C8 function based on multi-omics datasets

    These approaches can validate antibody-based findings and provide complementary insights into AKR4C8 biology that would be difficult to obtain using antibodies alone.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.